Fellowship · Columbus, OH
Sponsored by Ohio State University Hospital
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases.
Kidney international · 2021 · 757 citations · Brad Rovin, Kelly Burdge, Elizabeth Rave
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis.
The New England journal of medicine · 2025 · 194 citations · Brad Rovin
Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy.
The New England journal of medicine · 2025 · 161 citations · Brad Rovin
KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV).
Kidney international · 2025 · 125 citations · Brad Rovin
Impact of Portable Normothermic Blood-Based Machine Perfusion on Outcomes of Liver Transplant: The OCS Liver PROTECT Randomized Clinical Trial.
JAMA surgery · 2022 · 394 citations · Sylvester Black
Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.
Lancet (London, England) · 2021 · 476 citations · Brad Rovin, Samir Parikh
2024 American College of Rheumatology (ACR) Guideline for the Screening, Treatment, and Management of Lupus Nephritis.
Arthritis & rheumatology (Hoboken, N.J.) · 2025 · 101 citations · Brad Rovin, Jessica Greco
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial.
Lancet (London, England) · 2023 · 272 citations · Brad Rovin